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Twenty three clinical isolates of M. tuberculosis and the reference strain, M. tuberculosis H37Rv were
tested for their susceptibility to trifluoperazine (TFP) by the standard broth dilution method and the
bioluminescence assay. The results showed that in 15 of the 23 isolates, the minimal inhibitory
concentration (MIC) was identical in both the methods and in the remaining 8 isolates the difference
in the MIC values between the methods, was less than two fold and was not significant. The findings
suggest that the measurement of adenosine triphosphate (ATP) by bioluminescence assay can be
employed as an alternative method for the rapid screening of clinical isolates for their susceptibility
to anti-mycobacterial agents.
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In general, to determine the in vitro susceptibility
of Mycobacterium tuberculosis to anti-mycobacterial
agents, the broth dilution method or the agar dilution
method are used as standard procedures1. These
methods involve sampling, plating and counting the
colony forming units (cfu) to determine the bacterial
growth and its inhibition. These methods are
laborious, time consuming and the results are known
only after 5 wk. There is hence, an urgent need to
develop a rapid and reliable method for testing the
antimicrobial sensitivity of M. tuberculosis. As there
is a fairly good correlation between the ATP content
and the viable counts of M. tuberculosis, the
bioluminescence assay of ATP was suggested as an
alternative, rapid and reliable method2. However,
the correlation of the bioluminescence assay with the
broth dilution method in the determination of drug
sensitivity of M. tuberculosis to antitubercular drugs,
has not been reported in literature. The present study
describes the determination of minimal inhibitory
concentration (MIC) of trifluoperazine (TFP), an
antipsychotic drug with anti-mycobacterial activity3,
against M. tuberculosis by the standard broth dilution
method and the bioluminescence assay.
Material & Methods
Cultures : A total of 23 clinical isolates of M.
tuberculosis, obtained from pulmonary tuberculosis
patients attending Tuberculosis Research Centre,
Chennai, was studied. The reference strain, M.
tuberculosis H37Rv was included as control. All the
cultures were coded before testing.
Broth dilution method : The broth dilution method,
using Middlebrook 7H9 broth (BBL Microbiology
Systems, Cockeyville, Md) supplemented with
OADC (oleic acid, bovine albumin- factor - V,
dextrose, catalase) and 0.05 per cent Tween 80, was
set up as per the procedures described by Dickinson
and Mitchison4. In brief, a 7 day old 7H9 broth
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cul ture  was  adjus ted,  based on the  Thoma
bacteriological counter readings, to contain 106
bacilli/ml and distributed in bottles. TFP (gift from
Dr P.S Murthy, University College of Medical
Sciences. Delhi) was added to the culture bottles to
attain final concentrations of 8, 16, 32 and 64 mg/l.
The drug free culture was used as control. The culture
bottles were incubated at 37°C for 7 days. The viable
counts (VC) and the measurements of adenosine
triphosphate (ATP) were determined for the cultures.
The VC was determined, on day 0 for the control
culture and on day 7 for ail the cultures, by
inoculating undiluted and 5 serial ten-fold dilutions
of the cultures on Lowenstein-Jensen (LJ) medium
slopes and counting the cfu at the end of 4 wk. MIC
is defined as the lowest concentration of the drug
which inhibited more than 99 per cent of the
population in the control culture on day 7.
Bioluminescence assay of ATP : The extraction of
ATP and its measurement by the bioluminescence
assay were carried out by the procedures described
by Prioli et al 2. In preliminary experiments the
extraction of ATP was optimised. In brief, 100 µl of
the culture was transferred to 200 µ l of boiling 0.1
M Tris buffer (PH 7.75) containing 2 mM EDTA in
a test tube. After boiling for 5 min in a water-bath the
contents were cooled to room temperature. Then, 100
µl of the ATP monitoring reagent (Lumit, Lumac,
Netherlands) was added and the light intensity was
measured in a Biocounter (Lumac 3M, Biocounter
2010 A) as integral relative light units (RLU) in 10
sec.
Standard ATP curve : The Lumit ATP (10 µg/vial)
was diluted in Lumit buffer to contain different
concentrations ranging from 25,000 to 48 pg/ml and
their RLU values were determined.
Estimation of ATP content of M. tuberculosis : The
ATP content of the M. tuberculosis cultures was
estimated from the equation (ATP = 0.486 + 0.452
cfu) derived from the cfu and ATP values.
Determination of RLU index : As the ATP content of
mycobacterial cultures was estimated from the RLU
values the conversion of RLU values into ATP
content was not done and RLU values were used for
the analysis. The RLU index was calculated by
dividing the RLU of the drug containing culture on
day 7 by the RLU of the drug free control culture.
The MIC is defined as the lowest concentration of
the drug at which the RLU index is less than 0.1.
Statistical analysis : The difference in the agreement
between the  two methods was analysed by
McNamar’s test. The strength of the relationship
between the variables was measured using Pearson’s
correlation coefficient and their linear relationship
using regression lines.
Results & Discussion
The correlation coefficient between the standard
ATP and RLU was 0.998. The correlation between
cfu/RLU and ATP was 0.89 and they were significant.
The average content of ATP/cfu of M. tuberculosis
was estimated to be 5.36 x 10-15g. Similar values
were reported for mycobacteriai cultures by Katoch
et a15.
The distribution of MICs of TFP as determined by
the broth dilution and bioluminescence assay is given
in the Table. The MIC of 15 of the 23 strains was
identical in both the methods. Of the remaining 8
isolates, none exhibited a two fold difference in the
MIC value which is considered significant in bacterial
susceptibility tests. The difference observed between
the two methods was not statistically significant. In
two earlier studies6,7 the bioluminescence assay was
evaluated against the conventional indirect sensitivity
test and the Bactec radiometric assay for the
classification of M. tuberculosis cultures. Neisson et
al6 reported that the results of the bioluminescence
assay agreed with the conventional indirect sensitivity
test in 99 per cent (103/104) of test results and with
the radiometric assay in 98 per cent (102/104) of test
results, using 25 strains. Beckers et al7 observed that
Table. Comparison of values of MIC obtained by the broth dilution
and bioluminescence assay
Broth dilution method
MIC
MIC 8 16 32 Total
B i o l u m i n e s c e n c e  8 0 5 0
assay method 16 1 13 1 15
32 0 2 3
Total 1 19 3 23
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the bioluminescence assay correlated with the indirect
sensitivity test in 97 per cent (66/68) of the test
results using 17 clinical isolates.
The other rapid methods that are being explored
have their own limitations. The slide culture
sensitivity test is prone to produce contagious
aerosols and is difficult to perform in the routine set-
up. In addition, it is unsuitable for the smear-negative
but culture-positive samples since about 40 per cent
of the samples fail to grow in the slide culture
method8. The direct sensitivity test, based on
inoculation of the sputum deposit on the drug
containing LJ slopes, might give the susceptibility
pattern of the isolates within 10 to 14 days but, it
requires a reasonable number of bacilli in the deposit
to get reliable results9. The radiometric assay is very
well standardised and it is recommended for use in
the routine mycobacteriology laboratories 1 0 .
However, it also involves the use of radioactive
isotopes and hence is a potential health hazard.
Recent molecular methods such as polymerase chain
reaction-single strand conformation polymorphism
and the direct DNA sequencing techniques are very
expensive11-13 and their value needs to be evaluated
in large clinical trials. The luciferase myco-
bacter iophage repor ter  assay  i s  s t i l l  in  the
experimental stage and much more needs to be done
before it could be used in the laboratory14.
The results of the present study suggest that
bioluminescence assay could be adopted as one of
the methods for the determination of MIC of new
anti-mycobacterial agents against M. tuberculosis.
As the results of the bioluminescence assay are
available. in 14 days compared to 35 days in the
broth dilution method, it can be employed for the
rapid screening of clinical isolates/laboratory strains
for their susceptibility to anti-mycobacterial agents.
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